
Become a Royal Marsden Pioneer
Your monthly gift could save more lives
The Royal Marsden is renowned for leading and pioneering the research behind life-saving treatments for people with cancer everywhere. With one in two of us likely to receive a diagnosis in our lifetime, cancer touches every family, generation and community, which is why we need new research breakthroughs more than ever before.
For every £1 we raise 73p is made available for The Royal Marsden’s groundbreaking work.*
You don't have to develop a new cancer treatment to be a Royal Marsden Pioneer, simply set up a monthly donation today. You will receive a free keyring as a token of our thanks.

“Research has ultimately saved my life.”
When Pip, a former nurse, was diagnosed with stage 4 metastatic bowel cancer in 2016, she was told her cancer couldn’t be cured.
Pip's cancer had a genetic mutation which meant she was able to undergo targeted antibody treatment. Initially this helped shrink her tumours, but when Pip underwent a liver resection and hysterectomy surgery, her doctors saw that some of her tumours had started to grow again. Pip was also found to have a rare gene defect which made her eligible for an immunotherapy trial taking place at The Royal Marsden.
Thanks to the trial, over 8 years on from her diagnosis, Pip's scans are still showing no evidence of disease.

“Thanks to CAR-T therapy, I’ve now got my life back”
77-year-old Richard was diagnosed with myeloma, a type of blood cancer in August 2023. After hearing about research at The Royal Marsden, Richard joined the CARTITUDE-5 study and underwent CAR-T treatment in September. He was the first CAR-T patient to be treated in Sutton. CAR-T is a type of immunotherapy, personalised for each individual patient by collecting and re-engineering their T cells, harnessing the patient’s own immune system to fight cancer.
Cancer rates are set to rise by 40% by 2025 Source: JAMA Oncology estimates a 41.7% rise in very high–HDI countries and IARC/WHO data show a 37% increase in the UK.
*2024/25 annual report
Header image photographer: Kirsten Holt